JBT 10-Q Summary — Quarter Ended March 31, 2023
Business context: John Bean Technologies Corporation (JBT) provides equipment and services to food and beverage customers through FoodTech and to air transportation customers through AeroTech. This unaudited Form 10-Q covers the first quarter of 2023; comparisons are with the first quarter of 2022 unless noted.
Financial performance
| Metric | Q1 2023 | Q1 2022 / comparison |
|---|---|---|
| Revenue | $529.5 million | $469.2 million; up 12.9% |
| Gross profit / margin | $158.4 million / 29.9% | $139.5 million / 29.7% |
| Operating income / margin | $40.0 million / 7.6% | $30.6 million / 6.5% |
| Net income | $25.6 million | $25.6 million |
| Basic and diluted EPS | $0.80 | $0.80 |
| Operating cash flow | $21.6 million | $39.1 million |
| Capital expenditures | $17.9 million | $26.7 million |
- Revenue growth comprised $36.5 million of organic growth and $34.2 million from acquisitions, partly offset by $10.4 million of unfavorable currency translation. Organic growth reflected higher recurring revenue, partly offset by lower non-recurring revenue.
- FoodTech revenue was $388.5 million, up 9.0%; segment operating profit was $46.3 million, up 16.0%, with an 11.9% margin versus 11.2%. AeroTech revenue was $141.0 million, up 24.9%; segment operating profit was $13.2 million, up 94.1%, with a 9.4% margin versus 6.0%.
- Inbound orders totaled $638.2 million versus $565.5 million. FoodTech orders were $405.9 million versus $411.8 million, while AeroTech orders were $232.3 million versus $153.7 million.
- Operating margin improved 110 basis points, reflecting higher pricing, fixed-cost leverage and favorable revenue mix. Net interest expense rose to $7.2 million from $2.1 million, primarily due to higher rates and acquisition-related borrowing. The effective tax rate was 21.4%, compared with 10.2%; the prior-year rate benefited from $3.2 million of discrete tax items.
Balance sheet, debt and liquidity
- Cash and cash equivalents were $45.7 million at March 31, 2023, down from $73.1 million at December 31, 2022. Cash flow from operations fell year over year, primarily due to inventory investment, payments of accounts payable and lower collections of customer advance payments.
- Long-term debt, net of issuance costs, was $956.5 million, with $0.8 million of short-term debt. Gross principal debt was $965.5 million: $563.0 million drawn on the revolving facility and $402.5 million of convertible notes. The revolver’s weighted-average interest rate was 5.54%.
- The company reported $730.6 million of revolver availability and stated total liquidity of $542.8 million, defined as cash plus borrowing ability. It was in compliance with credit agreement covenants at quarter-end and expected to remain compliant.
- Cash used in investing activities was $18.9 million; cash used in financing activities was $30.0 million, including $25.9 million of net payments on domestic credit facilities and $3.2 million of dividends. Cash decreased $27.4 million during the quarter.
- Current assets were $866.2 million and current liabilities were $618.3 million. Inventory increased to $351.9 million from $322.5 million at year-end.
Outlook, strategy and notable items
- Management anticipated revenue growth in both segments through 2023, citing continued demand and record backlog entering the year. Remaining performance obligations were $1.2 billion; JBT expected to recognize 70% in 2023 and 25% in 2024.
- Management cited ongoing supply-chain, inflation and labor pressures, while expecting mitigation from pricing, productivity and strategic sourcing. Its medium-term goal is operating-margin improvement of 200 basis points or more, primarily through supply-chain and sourcing initiatives.
- JBT said it is pursuing a sale of AeroTech as part of its strategy to become a pure-play food and beverage solutions company. No sale terms or completion timetable are provided in this filing.
- JBT estimated full-year 2023 capital expenditures of $60 million to $70 million, including $12 million to $14 million for its OmniBlu digital platform. It expected positive cash flow for 2023 and estimated that required U.S. R&D tax amortization would reduce 2023 operating cash flow by approximately $20 million.
- The 2022/2023 FoodTech restructuring plan had incurred $6.0 million of cumulative charges by quarter-end; total estimated charges were $8 million to $10 million by year-end 2023. Expected cumulative savings were $9 million to $12 million, including $5 million to $6 million expected in 2023.
- JBT expected $14.5 million of pension and post-retirement plan contributions in 2023; none had been made to the U.S. qualified pension plan through March 31.
Risks and contingencies
- Key stated risks include economic deterioration, supply constraints and inflation, customer and sales-cycle changes, foreign-exchange and interest-rate movements, acquisition execution, geopolitical events, cyber incidents, and the ability to complete strategic alternatives for AeroTech. The filing reported no material change to the risk factors in the 2022 Form 10-K.
- Standby letters of credit, performance and surety bonds, and other guarantees totaled $165.7 million. Separate bank guarantees and letters of credit securing existing obligations were approximately $6.2 million. Customer financing guarantees had gross value of $2.0 million and stated net exposure of $0.3 million.
- Management said pending or threatened legal matters were not expected to have a material adverse effect on overall results or financial position, but acknowledged an unfavorable resolution could materially affect a particular future period. No material legal proceeding developments were reported for the quarter.
- Approximately $313 million, or 32% of total outstanding debt, remained subject to floating market rates. Higher rates could increase interest expense. The filing also identifies possible additional U.S. and foreign withholding taxes if certain foreign cash is repatriated.
Important facts for investors to verify
- Progress, terms and timing of the planned AeroTech sale and any impact on reported segments or capital allocation.
- Whether recurring-revenue growth, order trends and the $1.2 billion performance-obligation schedule convert into revenue as expected.
- Inventory and working-capital trends, cash conversion, the R&D tax amortization cash impact, and the stated 2023 cash-flow outlook.
- Interest-rate exposure, covenant headroom and the basis for the reported $542.8 million liquidity figure alongside disclosed revolver availability.
- Delivery of restructuring savings and margin targets while managing inflation, supply constraints and OmniBlu investment costs.